Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma
Completed
- Conditions
- Melanoma
- Interventions
- Behavioral: questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided
- Registration Number
- NCT00745862
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to examine the experiences and quality of life of women who have been treated for melanoma. By quality of life, we mean how they are feeling about different aspects of their life. In this study, we are especially interested in their feelings about survival, physical appearance and any family concerns. We will administer a series of QOL questionnaires, data sheets with many questions, to get their response to measure their feelings about these issues.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 118
Inclusion Criteria
- Age 18 years or older
- Clinically node-negative primary cutaneous melanoma.
- Patients participating must be female
- Patients must have completed surgical treatment for melanoma at least 10 days ago and less than 2 years at the time of study entry.
Read More
Exclusion Criteria
- Prior history of cancer with the exception of squamous or basal cell carcinoma of the skin.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided female patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment
- Primary Outcome Measures
Name Time Method To measure illness related distress regarding survival, family planning and functioning, and aesthetic satisfaction and QOL in post-surgical female patients diagnosed with clinically localized primary cutaneous melanoma. conclusion of study
- Secondary Outcome Measures
Name Time Method To examine the impact of illness related distress on QOL in women treated for clinically localized primary cutaneous melanoma. conclusion of study
Trial Locations
- Locations (1)
Memorial Sloan-Kettering Cancer Center
🇺🇸New York, New York, United States